Literature DB >> 7872260

DNA typing of the human MN and Ss blood group antigens in amniotic fluid and following massive transfusion.

J R Eshleman1, S H Shakin-Eshleman, A Church, J A Kant, S L Spitalnik.   

Abstract

Although red blood cell (RBC) antigen typing by agglutination is generally useful, several situations exist where this approach is difficult or impossible. For example, following a massive transfusion, a patient's residual RBCs are mixed with transfused normal donor RBCs. In this case, typing by hemagglutination primarily detects the antigens on the heterogeneous population of transfused RBCs. Agglutination testing is also of limited use for determining the phenotype of a fetus at risk for hemolytic disease of the newborn because fetal RBCs must be obtained by periumbilical blood sampling. Determining the genotype of an individual by analyzing genomic DNA isolated from peripheral blood nucleated cells or amniocytes is an alternative approach for determining the RBC antigen type. In this report, the allele specific polymerase chain reaction (AS-PCR) was used to identify the alleles at the MN and Ss loci that encode the corresponding antigens on glycophorin A (GPA) and glycophorin B (GPB), respectively. This method was used to type these alleles in peripheral blood samples obtained from normal individuals and from patients following massive transfusion. Of 23 peripheral blood specimens analyzed, all were correctly typed by this method. The allele specific polymerase chain reaction was also used to determine these alleles using amniotic fluid samples. Of 11 amniotic fluid specimens analyzed, 8 were correctly typed at both loci. Mistyping of three amniotic fluid specimens was explained by possible maternal blood contamination.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7872260     DOI: 10.1093/ajcp/103.3.353

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Single PCR multiplex SNaPshot reaction for detection of eleven blood group nucleotide polymorphisms: optimization, validation, and one year of routine clinical use.

Authors:  Julie Di Cristofaro; Monique Silvy; Jacques Chiaroni; Pascal Bailly
Journal:  J Mol Diagn       Date:  2010-04-29       Impact factor: 5.568

2.  Molecular immunohaematology round table discussions at the AABB Annual Meeting, Philadelphia 2014.

Authors:  Willy A Flegel; Shirley L De Castilho; Margaret A Keller; Ellen B Klapper; Joann M Moulds; France Noizat-Pirenne; Nadine Shehata; Gary Stack; Maryse St-Louis; Christopher A Tormey; Dan A Waxman; Christof Weinstock; Silvano Wendel; Gregory A Denomme
Journal:  Blood Transfus       Date:  2015-12-21       Impact factor: 3.443

3.  Why do we use serological blood group phenotype determination in chronically transfused patients?

Authors:  Franz F Wagner
Journal:  Blood Transfus       Date:  2013-12-11       Impact factor: 3.443

4.  RHD positive haplotypes in D negative Europeans.

Authors:  F F Wagner; A Frohmajer; W A Flegel
Journal:  BMC Genet       Date:  2001-07-16       Impact factor: 2.797

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.